Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition
- PMID: 27516116
- PMCID: PMC5029440
- DOI: 10.1093/jnen/nlw072
Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition
Abstract
Vascular risk factors (VRFs) have been associated with clinically diagnosed Alzheimer disease (AD), but few studies have examined the association between VRF and AD neuropathology (ADNP) in cognitively normal individuals. We used longitudinal data from the National Alzheimer's Disease Center's Uniform Data Set and Neuropathology Data Set to examine the association between VRF and ADNP (moderate to frequent neuritic plaques; Braak stage III-VI) in those with normal cognition. Our sample included 53 participants with ADNP and 140 without ADNP. Body mass index (BMI), resting heart rate (HR), and pulse pressure (PP) were measured at each visit; values were averaged across participant visits and examined annual change in BMI, PP, and HR. Hypertension, diabetes, and hypercholesterolemia were self-reported. In the multivariable logistic regression analyses, average BMI and HR were associated with lower odds of ADNP, and annual increases in HR and BMI were associated with higher odds of ADNP. A previously experienced decline in BMI or HR in late-life (therefore, currently low BMI and low HR) as well as a late-life increase in BMI and HR may indicate underlying AD pathology. Additional clinicopathological research is needed to elucidate the role of changes in late-life VRF and AD pathogenesis.
Keywords: Alzheimer disease; Asymptomatic; Body mass index; Heart rate; Neuropathology; Normal cognition; Vascular risk factor..
© 2016 American Association of Neuropathologists, Inc. All rights reserved.
Figures
Similar articles
-
Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.J Alzheimers Dis. 2017;57(3):953-968. doi: 10.3233/JAD-161205. J Alzheimers Dis. 2017. PMID: 28304301 Free PMC article.
-
A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.J Alzheimers Dis. 2018;63(4):1347-1360. doi: 10.3233/JAD-180017. J Alzheimers Dis. 2018. PMID: 29843242 Free PMC article.
-
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721. JAMA Neurol. 2015. PMID: 26302353 Free PMC article.
-
A third of community-dwelling elderly with intermediate and high level of Alzheimer's neuropathologic changes are not demented: A meta-analysis.Ageing Res Rev. 2020 Mar;58:101002. doi: 10.1016/j.arr.2019.101002. Epub 2019 Dec 30. Ageing Res Rev. 2020. PMID: 31899366
-
Neuropathology of Alzheimer's disease: a critical update.J Neural Transm Suppl. 1998;54:77-95. doi: 10.1007/978-3-7091-7508-8_8. J Neural Transm Suppl. 1998. PMID: 9850917 Review.
Cited by
-
Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.J Alzheimers Dis. 2017;57(3):953-968. doi: 10.3233/JAD-161205. J Alzheimers Dis. 2017. PMID: 28304301 Free PMC article.
-
Cerebrovascular pathology in Down syndrome and Alzheimer disease.Acta Neuropathol Commun. 2017 Dec 1;5(1):93. doi: 10.1186/s40478-017-0499-4. Acta Neuropathol Commun. 2017. PMID: 29195510 Free PMC article.
-
Alzheimer's Retinopathy: Seeing Disease in the Eyes.Front Neurosci. 2020 Sep 8;14:921. doi: 10.3389/fnins.2020.00921. eCollection 2020. Front Neurosci. 2020. PMID: 33041751 Free PMC article. Review.
-
Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia.Alzheimers Dement. 2019 May;15(5):686-698. doi: 10.1016/j.jalz.2018.12.015. Epub 2019 Mar 7. Alzheimers Dement. 2019. PMID: 30852157 Free PMC article.
-
The Association Between Neuropathological Lesions and Body Mass Index Is Independent of Cognitive Abilities.J Alzheimers Dis. 2024;101(3):773-785. doi: 10.3233/JAD-231366. J Alzheimers Dis. 2024. PMID: 39213060 Free PMC article.
References
-
- Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease. Neurology 1992;42:1681–8 - PubMed
-
- Morris JC, Storandt M, McKeel DW, et al. Cerebral amyloid deposition and diffuse plaques in “normal” aging: Evidence for presymptomatic and very mild Alzheimer’s disease. Neurology 1996;46:707–19 - PubMed
-
- Delaère P, He Y, Fayet G, et al. Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. Neurobiol Aging 1993;14:191–5 - PubMed
-
- Hauw JJ, Vignolo P, Duyckaerts C, et al. Neuropathological study of 12 centenarians: the incidence of Alzheimer type senile dementia is not particularly increased in this group of very old patients. Rev Neurol (Paris) 1986;142:107–15 - PubMed
Grants and funding
- P30 AG013854/AG/NIA NIH HHS/United States
- UH2 NS100599/NS/NINDS NIH HHS/United States
- P50 AG005142/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- K23 NS102399/NS/NINDS NIH HHS/United States
- P50 AG016573/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- P50 AG025688/AG/NIA NIH HHS/United States
- P50 AG005133/AG/NIA NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
- UF1 NS100599/NS/NINDS NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- P30 AG019610/AG/NIA NIH HHS/United States
- P50 AG033514/AG/NIA NIH HHS/United States
- UH3 NS100599/NS/NINDS NIH HHS/United States
- P30 AG010124/AG/NIA NIH HHS/United States
- P50 AG023501/AG/NIA NIH HHS/United States
- P50 AG005131/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- P50 AG005146/AG/NIA NIH HHS/United States
- R01 AA022336/AA/NIAAA NIH HHS/United States
- P30 AG035982/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P50 AG005136/AG/NIA NIH HHS/United States
- P30 AG012300/AG/NIA NIH HHS/United States
- P50 AG016570/AG/NIA NIH HHS/United States
- P50 AG005134/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- F32 NS096803/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous